BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Non-Current Debt (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Non-Current Debt of $179,000 for FY2019, up 383.8% from $37,000 in FY2018.

Analysis

BridgeBio Pharma (BBIO) Non-Current Debt (2018 - 2026) Analysis & Trends

  • According to Business Quant data, Non-Current Debt came in at $37,000 in FY2018 (-72.0%) and $132,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn 1.93 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Bn
Mar 31, 2026 1.93 Bn
Dec 31, 2025 1.85 Bn
Sep 30, 2025 1.85 Bn
Dec 31, 2024 437.34 Mn
Sep 30, 2024 436.22 Mn
Jun 30, 2024 435.45 Mn
Mar 31, 2024 434.72 Mn
Dec 31, 2023 446.45 Mn
Sep 30, 2023 441.72 Mn
Jun 30, 2023 440.50 Mn
Mar 31, 2023 435.76 Mn
Dec 31, 2022 430.99 Mn
Sep 30, 2022 422.97 Mn
Jun 30, 2022 418.35 Mn
Mar 31, 2022 434.11 Mn
Dec 31, 2021 430.75 Mn
Sep 30, 2021 103.14 Mn
Jun 30, 2021 102.61 Mn
Mar 31, 2021 90.76 Mn
API Access

BridgeBio Pharma Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BBIO&period=max&api_key=YOUR_API_KEY